Crestline Management »

Rhythm Pharmaceuticals shares owned by Crestline Management

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Crestline Management from 13F filings

Historical chart of Crestline Management investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Crestline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Crestline Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $995k 19k 52.39
2018-06-30 $1.3M 41k 31.26

More positions owned by Crestline Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Denali Therapeutics (DNLI)
NVIDIA Corporation (NVDA)
salesforce (CRM)
Alcoa (AA)
Broadcom (AVGO)
Coherent Corp (COHR)
Norfolk Southern (NSC)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Evergy (EVRG)
PPL Corporation (PPL)
NiSource (NI)
Adobe Systems Incorporated (ADBE)
Perrigo SHS (PRGO)
Golar Lng SHS (GLNG)

View all positions for Crestline Management

Top funds holding Rhythm Pharmaceuticals

PRIMECAP Management Company
BlackRock
Baker Bros. Advisors
RA Capital Management
Goldman Sachs Group
Perceptive Advisors
Vanguard Group
NEA Management Company
Frazier Life Sciences Management
State Street Corporation
Federated Investors
Polar Capital Holdings
Driehaus Capital Management
Geode Capital Management
Rock Springs Capital Management

View all funds holding Rhythm Pharmaceuticals